Category:Monoclonal antibodies

Subcategories

This category has the following 29 subcategories, out of 29 total.

Media in category "Monoclonal antibodies"

The following 142 files are in this category, out of 142 total.

• 
  13045 2019 736 Fig1 HTML.jpg 778 × 541; 66 KB
  
• 
  280 2019 3875 Fig1 HTML.webp 685 × 534; 34 KB
  
• 
  3D Dual Color Super Resolution Microscopy Cremer 2010.png 3,486 × 1,280; 3 MB
  
• A-proteomic-approach-reveals-integrin-activation-state-dependent-control-of-microtubule-cortical-ncomms7135-s3.ogv 8.5 s, 512 × 512; 3.22 MB
  
• A-proteomic-approach-reveals-integrin-activation-state-dependent-control-of-microtubule-cortical-ncomms7135-s4.ogv 7.3 s, 512 × 512; 785 KB
  
• A-proteomic-approach-reveals-integrin-activation-state-dependent-control-of-microtubule-cortical-ncomms7135-s5.ogv 12 s, 900 × 675; 7.35 MB
  
• A-proteomic-approach-reveals-integrin-activation-state-dependent-control-of-microtubule-cortical-ncomms7135-s6.ogv 12 s, 900 × 675; 5.25 MB
  
• A-proteomic-approach-reveals-integrin-activation-state-dependent-control-of-microtubule-cortical-ncomms7135-s7.ogv 12 s, 900 × 675; 1.93 MB
  
• A-shear-gradient-activated-microfluidic-device-for-automated-monitoring-of-whole-blood-haemostasis-ncomms10176-s2.ogv 11 s, 1,200 × 453; 406 KB
  
• 
  Antibodyigg.png 776 × 702; 169 KB
  
• 
  Anticuerpo Monoclonal.png 950 × 776; 664 KB
  
• 
  Approaches for the development of therapeutic antibodies.webp 1,946 × 1,379; 227 KB
  
• 
  Atezolizumab for treatment of non small cell lung cancer in the first line, IMpower 110, 130 and 150 studies.jpg 492 × 935; 139 KB
  
• Autophagy-Facilitates-the-Development-of-Breast-Cancer-Resistance-to-the-Anti-HER2-Monoclonal-pone.0006251.s001.ogv 4.5 s, 1,024 × 576; 225 KB
  
• Autophagy-Facilitates-the-Development-of-Breast-Cancer-Resistance-to-the-Anti-HER2-Monoclonal-pone.0006251.s002.ogv 4.4 s, 856 × 480; 971 KB
  
• Autophagy-Facilitates-the-Development-of-Breast-Cancer-Resistance-to-the-Anti-HER2-Monoclonal-pone.0006251.s003.ogv 4.5 s, 856 × 480; 1.19 MB
  
• 
  BiologicsPatentCliff2011.pdf 1,614 × 958; 44 KB
  
• 
  Biomedicines-07-00018-g002.jpg 695 × 574; 51 KB
  
• 
  Cancer antibody receptor blockade.png 960 × 720; 61 KB
  
• 
  CertolizumaB 5WUV.png 1,600 × 1,600; 1.56 MB
  
• 
  Certolizumab binding TNF-alpha homotrimer 5WUX.png 2,000 × 2,000; 1.56 MB
  
• 
  Construction and affinity selection with phage-display antibody library.webp 1,415 × 1,435; 152 KB
  
• Cytokeratin-8-ectoplasmic-domain-binds-urokinase-type-plasminogen-activator-to-breast-tumor-cells-1476-4598-8-88-S2.ogv 40 s, 240 × 180; 1.19 MB
  
• Cytokeratin-8-ectoplasmic-domain-binds-urokinase-type-plasminogen-activator-to-breast-tumor-cells-1476-4598-8-88-S3.ogv 40 s, 240 × 180; 2.02 MB
  
• 
  Depemokimab chemical structure.jpg 240 × 244; 12 KB
  
• 
  Determinación de grupo sanguíneo AB+ y B+.png 542 × 674; 597 KB
  
• 
  Development of better monoclonal antibodies for human therapy and their nomenclature.svg 2,144 × 892; 85 KB
  
• 
  Diagrammatic illustration of the mechanism of two monoclonal antibodies utilized for treating eosinophilic asthma.webp 1,944 × 1,156; 167 KB
  
• ER-Bound-Protein-Tyrosine-Phosphatase-PTP1B-Interacts-with-Src-at-the-Plasma-MembraneSubstrate-pone.0038948.s007.ogv 4.0 s, 312 × 332; 77 KB
  
• 
  Factors affecting Immunogenicity of Monoclonal Antibodies.png 2,732 × 1,544; 1.88 MB
  
• 
  Fendo-14-1236946-g003.jpg 2,060 × 941; 214 KB
  
• 
  Fimmu-14-1145145-g001.jpg 3,506 × 2,478; 633 KB
  
• Fluorescently-tagged-anti-ganglioside-antibody-selectively-identifies-peripheral-nerve-in-living-srep15766-s2.ogv 20 s, 320 × 240; 121 KB
  
• Fluorescently-tagged-anti-ganglioside-antibody-selectively-identifies-peripheral-nerve-in-living-srep15766-s3.ogv 5.8 s, 320 × 240; 104 KB
  
• Fluorescently-tagged-anti-ganglioside-antibody-selectively-identifies-peripheral-nerve-in-living-srep15766-s4.ogv 5.8 s, 320 × 240; 41 KB
  
• 
  Fonc-11-582664-g004.webp 290 × 248; 10 KB
  
• 
  FOURIER RESULTS GRAPH.png 1,653 × 1,235; 36 KB
  
• FYVE-Dependent-Endosomal-Targeting-of-an-Arrestin-Related-Protein-in-Amoeba-pone.0015249.s007.ogv 12 s, 256 × 256; 112 KB
  
• Generation-of-functional-scFv-intrabody-to-abate-the-expression-of-CD147-surface-molecule-of-293A-1472-6750-8-5-S1.ogv 52 s, 864 × 672; 1.69 MB
  
• High-Affinity-Antigen-Recognition-of-the-Dual-Specific-Variants-of-Herceptin-Is-Entropy-Driven-in-pone.0017887.s001.ogv 7.4 s, 640 × 480; 424 KB
  
• 
  How hCG Is Used To Indicate a Positive Pregnancy Test.svg 512 × 307; 210 KB
  
• 
  How to obtain monoclonal antibodies.jpg 3,968 × 2,976; 3.83 MB
  
• 
  IG-scFv-TCR fusion protein.svg 328 × 230; 90 KB
  
• 
  Ijms-23-07908-g001.png 4,299 × 1,851; 3.52 MB
  
• 
  Ijms-23-11166-g001-550- 1.jpg 550 × 406; 37 KB
  
• 
  Immunoglobulin G1-kappa, anti-CD3E + anti-MS4A1 bispecific.svg 260 × 288; 118 KB
  
• 
  Immunoglobulin G4-lambda, anti-CD3E + anti-TNFRSF17 bispecific.svg 260 × 288; 106 KB
  
• Intermolecular-biparatopic-trapping-of-ErbB2-prevents-compensatory-activation-of-PI3KAKT-via-ncomms11672-s2.ogv 19 s, 800 × 800; 11.67 MB
  
• Intermolecular-biparatopic-trapping-of-ErbB2-prevents-compensatory-activation-of-PI3KAKT-via-ncomms11672-s3.ogv 20 s, 800 × 800; 22.83 MB
  
• 
  Jcm-12-00168-g002-550.webp 550 × 245; 14 KB
  
• 
  Mechanism of Action of Dalotuzumab.jpg 960 × 540; 72 KB
  
• 
  Mechanism of action of mAb in the treatment of multiple sclerosis.webp 685 × 671; 64 KB
  
• 
  Moabs I - Moabs Production.png 649 × 791; 212 KB
  
• 
  Moabs II - Anticuerpos quiméricos.png 628 × 379; 56 KB
  
• 
  Moabs III - Anticuerpos Humanizados.png 647 × 412; 63 KB
  
• 
  Moabs IV - Mejoras de las Funciones Efectoras.png 706 × 783; 75 KB
  
• 
  Moabs V - Inmunotoxinas.png 598 × 310; 30 KB
  
• 
  Moabs VI - Conjugado con Enzimas.png 572 × 144; 12 KB
  
• 
  Moabs VII - Inmunocitotoxinas.png 319 × 177; 11 KB
  
• 
  Moabs VIII - Anticuerpos Biespecíficos.png 276 × 189; 7 KB
  
• Monitoring-the-Systemic-Human-Memory-B-Cell-Compartment-of-Melanoma-Patients-for-Anti-Tumor-IgG-pone.0019330.s003.ogv 4.0 s, 1,388 × 1,040; 559 KB
  
• Monitoring-the-Systemic-Human-Memory-B-Cell-Compartment-of-Melanoma-Patients-for-Anti-Tumor-IgG-pone.0019330.s004.ogv 4.0 s, 1,388 × 1,040; 925 KB
  
• 
  Monoclonal antibodies (1).jpg 2,700 × 1,800; 2.07 MB
  
• 
  Monoclonal antibodies (2).jpg 2,700 × 1,800; 1.87 MB
  
• 
  Monoclonal antibodies (3).jpg 2,700 × 1,800; 2.11 MB
  
• 
  Monoclonal antibodies (4).jpg 1,800 × 2,700; 2.59 MB
  
• 
  Monoclonal antibodies (5).jpg 2,700 × 1,800; 2.44 MB
  
• 
  Monoclonal antibodies (6).jpg 2,700 × 1,800; 2.09 MB
  
• 
  Monoclonal antibodies (7).jpg 2,700 × 1,800; 1.64 MB
  
• 
  Monoclonal antibodies (8).jpg 2,700 × 1,800; 2.35 MB
  
• 
  Monoclonal antibodies (9).jpg 1,800 × 2,435; 1.3 MB
  
• 
  Monoclonal antibodies (colon).jpg 2,124 × 1,800; 1.12 MB
  
• 
  Monoclonal antibodies (mAbs) (14050986246).jpg 972 × 962; 303 KB
  
• 
  Monoclonal antibodies smaller.jpg 387 × 555; 53 KB
  
• 
  Monoclonal antibodies used in the treatment of non small cell lung cancer and their mechanism of action.webp 550 × 354; 23 KB
  
• 
  Monoclonal antibodies1.jpg 1,350 × 900; 602 KB
  
• 
  Monoclonal antibodies2.jpg 1,350 × 900; 452 KB
  
• 
  Monoclonal antibodies3.jpg 2,700 × 1,800; 2.24 MB
  
• 
  Monoclonal antibody.jpg 686 × 347; 29 KB
  
• 
  Monoclonal Antibody.webp 345 × 336; 11 KB
  
• Monoclonal-Antibodies-Against-Peptidorhamnomannans-of-Scedosporium-apiospermum-Enhance-the-pntd.0000853.s003.ogv 28 s, 720 × 540; 5.49 MB
  
• 
  Natalizumab 4IRZ.png 2,048 × 2,048; 155 KB
  
• 
  Ocrelizumab.png 792 × 558; 357 KB
  
• 
  Overview of monoclonal antibody therapies.webp 2,879 × 2,112; 175 KB
  
• Patterned-Cell-Adhesion-Associated-with-Tissue-Deformations-during-Dorsal-Closure-in-Drosophila-pone.0027159.s004.ogv 6.9 s, 512 × 512; 15.51 MB
  
• 
  Pembrolizumab results as in Lung cancer keynote studies KEYNOTE-024 KEYNOTE-042 KEYNOTE-189 KEYNOTE-407.jpg 1,020 × 601; 172 KB
  
• 
  Pembrolizumab.webp 290 × 340; 7 KB
  
• 
  Pharmaceuticals-13-00373-g002-550.jpg 550 × 536; 96 KB
  
• 
  Producción Anticuerpo Monoclonal.png 544 × 305; 143 KB
  
• 
  Prof.Joseph Gligorov from Paris, Dr.Nikola Vasev, Dr.Milan Risteski, Prof.Dr.Petar Stefanovski from Skopje.JPG 4,320 × 3,240; 783 KB
  
• 
  REGN-COV2 binding SARS-CoV-2 spike protein.png 2,048 × 2,048; 292 KB
  
• 
  S41467-020-16256-y.pdf 1,239 × 1,629, 6 pages; 2.77 MB
  
• 
  Schematic overview of antibody humanization from murine antibodies (green domains) to fully human antibodies and associated suffixes.webp 1,180 × 1,332; 73 KB
  
• 
  Schematic overview showing the development of antibody-based therapeutics for the treatment of cancer.webp 1,408 × 1,053; 178 KB
  
• 
  Sifalimumab 4YPG.png 1,353 × 2,048; 149 KB
  
• Signaling-Signatures-and-Functional-Properties-of-Anti-Human-CD28-Superagonistic-Antibodies-pone.0001708.s004.ogv 45 s, 688 × 516; 15.66 MB
  
• Signaling-Signatures-and-Functional-Properties-of-Anti-Human-CD28-Superagonistic-Antibodies-pone.0001708.s005.ogv 29 s, 688 × 516; 5.71 MB
  
• 
  Siltuximab.pdf 1,275 × 1,650, 16 pages; 211 KB
  
• 
  Some classic structures of BsAbs with CD3 as one of their targets.webp 2,362 × 1,671; 665 KB
  
• 
  Sotrovimab.jpg 2,476 × 2,773; 841 KB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S1.ogv 1.2 s, 516 × 484; 2.08 MB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S2.ogv 1.2 s, 514 × 484; 530 KB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S3.ogv 1.2 s, 516 × 484; 1.07 MB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S4.ogv 0.9 s, 516 × 484; 2.3 MB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S5.ogv 0.9 s, 516 × 484; 1.73 MB
  
• Staged-stromal-extracellular-3D-matrices-differentially-regulate-breast-cancer-cell-responses-1471-2407-9-94-S6.ogv 0.9 s, 516 × 484; 1.76 MB
  
• 
  Structural basis for inhibition of TSLP-signaling by Tezepelumab.png 3,600 × 2,355; 1.81 MB
  
• Structure-Function-Correlation-of-the-Human-Central-Retina-pone.0012864.s004.ogv 28 s, 638 × 486; 3.67 MB
  
• 
  T-cell killing cancer cell.gif 300 × 300; 1.02 MB
  
• 
  Tcrm-6-123f1.jpg 646 × 462; 103 KB
  
• The-Development-and-Characterization-of-a-Human-Mesothelioma-In-Vitro-3D-Model-to-Investigate-pone.0014640.s001.ogv 13 s, 516 × 512; 3.77 MB
  
• The-Development-and-Characterization-of-a-Human-Mesothelioma-In-Vitro-3D-Model-to-Investigate-pone.0014640.s002.ogv 13 s, 516 × 512; 2.35 MB
  
• The-Glycan-Role-in-the-Glycopeptide-Immunogenicity-Revealed-by-Atomistic-Simulations-and-srep09200-s3.ogv 12 s, 640 × 246; 1 MB
  
• The-Glycan-Role-in-the-Glycopeptide-Immunogenicity-Revealed-by-Atomistic-Simulations-and-srep09200-s4.ogv 12 s, 640 × 246; 1.18 MB
  
• The-immune-synapse-clears-and-excludes-molecules-above-a-size-threshold-ncomms6479-s2.ogv 5.0 s, 219 × 219; 350 KB
  
• The-immune-synapse-clears-and-excludes-molecules-above-a-size-threshold-ncomms6479-s3.ogv 5.0 s, 219 × 219; 419 KB
  
• The-pericyte-as-a-cellular-regulator-of-penile-erection-and-a-novel-therapeutic-target-for-erectile-srep10891-s2.ogv 5.5 s, 800 × 800; 696 KB
  
• The-pericyte-as-a-cellular-regulator-of-penile-erection-and-a-novel-therapeutic-target-for-erectile-srep10891-s3.ogv 6.5 s, 808 × 808; 3.78 MB
  
• The-pericyte-as-a-cellular-regulator-of-penile-erection-and-a-novel-therapeutic-target-for-erectile-srep10891-s4.ogv 11 s, 808 × 808; 3.5 MB
  
• The-pericyte-as-a-cellular-regulator-of-penile-erection-and-a-novel-therapeutic-target-for-erectile-srep10891-s5.ogv 5.8 s, 808 × 808; 3.02 MB
  
• The-pericyte-as-a-cellular-regulator-of-penile-erection-and-a-novel-therapeutic-target-for-erectile-srep10891-s6.ogv 5.8 s, 808 × 808; 1.52 MB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s009.ogv 21 s, 512 × 512; 1,003 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s010.ogv 6.2 s, 512 × 512; 285 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s011.ogv 15 s, 512 × 512; 273 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s012.ogv 11 s, 512 × 512; 221 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s013.ogv 10 s, 512 × 512; 701 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s014.ogv 5.0 s, 512 × 512; 304 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s015.ogv 18 s, 512 × 512; 547 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s016.ogv 17 s, 512 × 512; 812 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s017.ogv 10 s, 512 × 512; 387 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s018.ogv 12 s, 512 × 512; 502 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s019.ogv 8.2 s, 512 × 512; 445 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s020.ogv 32 s, 512 × 512; 670 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s021.ogv 26 s, 512 × 512; 1.33 MB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s022.ogv 13 s, 512 × 512; 188 KB
  
• The-Use-of-Spinning-Disk-Confocal-Microscopy-for-the-Intravital-Analysis-of-Platelet-Dynamics-in-pone.0025109.s023.ogv 24 s, 512 × 512; 361 KB
  
• Tissue-and-Stage-Specific-Distribution-of-Wolbachia-in-Brugia-malayi-pntd.0001174.s002.ogv 8.2 s, 352 × 288; 62 KB
  
• Tissue-and-Stage-Specific-Distribution-of-Wolbachia-in-Brugia-malayi-pntd.0001174.s003.ogv 8.2 s, 352 × 288; 79 KB
  
• Tissue-and-Stage-Specific-Distribution-of-Wolbachia-in-Brugia-malayi-pntd.0001174.s004.ogv 8.2 s, 320 × 240; 54 KB
  
• 
  Tralokinumab 5L6Y.png 1,851 × 1,467; 137 KB
  
• 
  Vaccines-11-01756-g005-550.webp 550 × 412; 27 KB
  
• 
  VEGF-inhibitors v.01.svg 820 × 400; 94 KB